These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37224673)

  • 1. Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence.
    Brandt L; Hu MC; Nunes EV; Campbell ANC
    Drug Alcohol Depend; 2023 Jul; 248():109918. PubMed ID: 37224673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.
    Miguel AQC; Kiluk BD; Babuscio TA; Nich C; Mari JJ; Carroll KM
    Drug Alcohol Depend; 2019 May; 198():126-132. PubMed ID: 30921648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
    Kiluk BD; Fitzmaurice GM; Strain EC; Weiss RD
    Addiction; 2019 Jan; 114(1):9-15. PubMed ID: 29900624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social functioning outcomes among individuals with substance use disorders receiving internet-delivered community reinforcement approach.
    Marino LA; Campbell ANC; Pavlicova M; Hu M; Nunes EV
    Subst Use Misuse; 2019; 54(7):1067-1074. PubMed ID: 30849925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance on Cognitive Screening Tests and Long-Term Substance Use Outcomes in Patients with Polysubstance Use Disorder.
    Hetland J; Hagen E; Lundervold AJ; Erga AH
    Eur Addict Res; 2023; 29(2):150-159. PubMed ID: 37080181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstinence versus moderation recovery pathways following resolution of a substance use problem: Prevalence, predictors, and relationship to psychosocial well-being in a U.S. national sample.
    Eddie D; Bergman BG; Hoffman LA; Kelly JF
    Alcohol Clin Exp Res; 2022 Feb; 46(2):312-325. PubMed ID: 34931320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding site variability in a multisite clinical trial of a technology-delivered psychosocial intervention for substance use disorders.
    Vaezazizi LM; Campbell ANC; Pavlicova M; Hu MC; Nunes EV
    J Subst Abuse Treat; 2019 Oct; 105():64-70. PubMed ID: 31443894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant characteristics associated with early treatment drug use versus abstinence.
    Cochran G; Stitzer M; Nunes EV; Hu MC; Campbell A
    Addict Sci Clin Pract; 2014 Apr; 9(1):6. PubMed ID: 24708748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol and cocaine abusers 6 months after traditional treatment: do they fare as well as problem drinkers?
    Brown TG; Seraganian P; Tremblay J
    J Subst Abuse Treat; 1993; 10(6):545-52. PubMed ID: 8308939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.
    Amin-Esmaeili M; Farokhnia M; Susukida R; Leggio L; Johnson RM; Crum RM; Mojtabai R
    Addiction; 2024 May; 119(5):833-843. PubMed ID: 38197836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.
    Shulman M; Campbell A; Pavlicova M; Hu MC; Aharonovich E; Nunes EV
    Am J Addict; 2018 Sep; 27(6):509-515. PubMed ID: 30091814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Outcome in the Treatment of Cocaine Dependence.
    Crits-Christoph P; Gallop R; Gibbons MB; Sadicario JS; Woody G
    J Alcohol Drug Depend; 2013 Mar; 1(2):. PubMed ID: 26366427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.
    Witkiewitz K; Kirouac M; Roos CR; Wilson AD; Hallgren KA; Bravo AJ; Montes KS; Maisto SA
    Psychol Addict Behav; 2018 Sep; 32(6):639-646. PubMed ID: 30160499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speak and you shall predict: speech at initial cocaine abstinence as a biomarker of long-term drug use behavior.
    Agurto C; Cecchi G; King S; Eyigoz EK; Parvaz MA; Alia-Klein N; Goldstein RZ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?
    Witkiewitz K; Wilson AD; Pearson MR; Montes KS; Kirouac M; Roos CR; Hallgren KA; Maisto SA
    Addiction; 2019 Jan; 114(1):69-80. PubMed ID: 30063267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.